Physicobiological properties and biocompatibility of biodegradable poly(oxalate-co-oxamide)

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 4, 2011, Pages 517-526

  Song, Yiseul ^a   Kwon, Jungil ^a   Kim, Byungkuk ^a   Jeon, Yuyong ^b   Khang, Gilson ^a   Lee, Dongwon ^a  

^a Chonbuk National University   (South Korea)

^b Inha University   (South Korea)

Author keywords

biodegradation; compatibility; inflammation; poly(oxalate co oxamide); polymer

Indexed keywords

BIOCOMPATIBLE MATERIALS; BIOMEDICAL APPLICATIONS; CELL ATTACHMENTS; COMPATIBILITY; GIANT CELLS; IN-VITRO; IN-VIVO; INFLAMMATION; INFLAMMATORY CELLS; INFLAMMATORY RESPONSE; MURINE MACROPHAGES; PHYSICOCHEMICAL PROPERTY; PHYSIOLOGICAL CONDITION; POLY(LACTIC-CO-GLYCOLIC ACID); POLY(OXALATE-CO-OXAMIDE); TUMOR NECROSIS FACTOR-ALPHA; WOUND DRESSINGS;

BIODEGRADATION; DEGRADATION; DRUG DELIVERY; MACROPHAGES; MEDICAL APPLICATIONS; RATING; TISSUE; TISSUE ENGINEERING;

BIOCOMPATIBILITY;

BIOMATERIAL; OXALIC ACID; POLY(OXALATE CO OXAMIDE); POLYGLACTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL ADHESION; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CELL VIABILITY; GIANT CELL; HYDROPHILICITY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; IMPLANTS, EXPERIMENTAL; LACTIC ACID; MACROPHAGES; MATERIALS TESTING; MICE; MOLECULAR STRUCTURE; OXALATES; OXAMIC ACID; POLYGLYCOLIC ACID; RATS; RATS, WISTAR;

EID: 80051472244     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33135     Document Type: Article

References (28)

1. Thevenot PT, Nair AM, Shen JH, Lotfi P, Ko CY, Tang LP,. The effect of incorporation of SDF-1 alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010; 31: 3997-4008.
2. Kim MS, Ahn HH, Shin YN, Cho MH, Khang G, Lee HB,. An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosa-based scaffolds. Biomaterials 2007; 28: 5137-5143. (Pubitemid 47496174)
3. Yoon SJ, Kim SH, Ha HJ, Ko YK, So JW, Kim MS, Il Yang Y, Khang G, Rhee JM, Lee HB,. Reduction of inflammatory reaction of poly(D,L-lactic-Co-glycolic acid) using demineralized bone particles. Tissue Eng Part A 2008; 14: 539-547. (Pubitemid 351520462)
4. Kim CH, Khil MS, Kim HY, Lee HU, Jahng KY,. An improved hydrophilicity via electrospinning for enhanced cell attachment and proliferation. J Biomed Mater Res B Appl Biomater 2006; 78B: 283-290. (Pubitemid 44167730)
5. Serrano MC, Pagani R, Vallet-Regi M, Pena J, Ramila A, Izquierdo I, Portoles MT,. In vitro biocompatibility assessment of poly(epsilon-caprolactone) films using L929 mouse fibroblasts. Biomaterials 2004; 25: 5603-5611. (Pubitemid 38680488)
6. Iwasaki Y, Sawada S, Ishihara K, Khang G, Lee HB,. Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer blend. Biomaterials 2002; 23: 3897-3903. (Pubitemid 34828163)
7. Malafaya PB, Silva GA, Reis RL,. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 2007; 59: 207-233. (Pubitemid 46879967)
8. Panilaitis B, Altman GH, Chen JS, Jin HJ, Karageorgiou V, Kaplan DL,. Macrophage responses to silk. Biomaterials 2003; 24: 3079-3085. (Pubitemid 36944938)
9. Yang YW, Hsu PYJ,. The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens. Biomaterials 2008; 29: 2516-2526.
10. Silva M, Cyster LA, Barry JJA, Yang XB, Oreffo ROC, Grant DM, Scotchford CA, Howdle SM, Shakesheff KM, Rose F,. The effect of anisotropic architecture on cell and tissue infiltration into tissue engineering scaffolds. Biomaterials 2006; 27: 5909-5917. (Pubitemid 44332515)
11. Sahoo S, Toh SL, Goh JCH,. PLGA nanofiber-coated silk microfibrous scaffold for connective tissue engineering. J Biomed Mater Res B Appl Biomater 2010; 95B: 19-28.
12. Ho ML, Fu YC, Wang GJ, Chen HT, Chang JK, Tsai TH, Wang CK,. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. J Control Release 2008; 128: 142-148.
13. Kim S, Seong K, Kim O, Seo H, Lee M, Khang G, Lee D,. Polyoxalate nanoparticles as a biodegradable and biocompatible drug delivery vehicle. Biomacromolecules 2010; 11: 555-560.
14. Park H, Kim S, Song Y, Seung K, Hong D, Khang G, Lee D,. Antioxidant and anti-inflammatory activities of hydroxybenzyl alcohol releasing biodegradable polyoxalate nanoparticles. Biomacromolecules 2010; 11: 2103-2108.
15. Holland SJ, Tighe BJ, Gould PL,. Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. J Control Release 1986; 4: 155-180. (Pubitemid 17204842)
16. Yim ES, Zhao B, Myung D, Kourtis LC, Frank CW, Carter D, Smith RL, Goodman SB,. Biocompatibility of poly(ethylene glycol)/poly (acrylic acid) interpenetrating polymer network hydrogel particles in RAW 264.7 macrophage and MG-63 osteoblast cell lines. J Biomed Mater Res A 2009; 91A: 894-902.
17. Meinel L, Hofmann S, Karageorgiou V, Kirker-Head C, McCool J, Gronowicz G, Zichner L, Langer R, Vunjak-Novakovic G, Kaplan DL,. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 2005; 26: 147-155. (Pubitemid 38789097)
18. Sy JC, Seshadri G, Yang SC, Brown M, Oh T, Dikalov S, Murthy N, Davis ME,. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater 2008; 7: 863-869.
19. Cao WL, Wang AJ, Jing DH, Gong YD, Zhao NM, Zhang XF,. Novel biodegradable films and scaffolds of chitosan blended with poly(3- hydroxybutyrate). J Biomater Sci Polym Ed 2005; 16: 1379-1394.
20. Leung L, Chan C, Baek S, Naguib H,. Comparison of morphology and mechanical properties of PLGA bioscaffolds. Biomed Mater 2008; 3: 025006.
21. Carbone AL, Uhrich KE,. Design and synthesis of fast-degrading poly(anhydride-esters). Macromol Rapid Commun 2009; 30: 1021-1026.
22. Huang X, Brazel CS,. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001; 73: 121-136. (Pubitemid 32539245)
23. Palsson BO, Bhatia SN,. Tissue Engineering. Upper Saddle River: Pearson; 2004.
24. Acharya C, Kumary TV, Ghosh SK, Kundu SC,. Characterization of fibroin and PEG-blended fibroin matrices for in vitro adhesion and proliferation of osteoblasts. J Biomater Sci Polym Ed 2009; 20: 543-565.
25. Murray DW, Rae T, Ruston N,. The influence of the surface energy and roughness of implants on bone resorption. J Bone Joint Surg 1989; 71-B: 632-637. (Pubitemid 19211223)
26. Wu Z, Zhang J, Nakanishi H,. Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation. J Neuroimmunol 2005; 167: 90-98. (Pubitemid 41242291)
27. Numata M, Suzuki S, Miyazawa N, Miyashita A, Nagashima Y, Inoue S, Kaneko T, Okubo T,. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 1998; 160: 3031-3037. (Pubitemid 28136760)
28. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A,. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-747. (Pubitemid 43357549)